Author: MarketNewsData
Your go-to source for real-time financial news and market analysis. Powered by AI. Covering earnings, economic events, and corporate news.
Biodexa Pharmaceuticals closes $6.0 million public offering and acquires diabetes program
From GlobeNewswire: Biodexa Pharmaceuticals PLC has announced the closing of a $6.0 million public offering, with the full exercise of
